The triple agonist mechanism produces the broadest range of metabolic benefits: superior liver fat reduction, dramatic insulin sensitivity improvement, significant lipid improvements, and meaningful blood pressure reduction
Funding This study was financially supported by statutory funds of the Maj Institute of Pharmacology, Polish Academy of Sciences, Krakw, Poland
Developing potential therapies that can be administered less frequently could benefit societies as well as individual patients, and it is a clear focus area for Novo Nordisk, commented Brian Vandahl, Senior Vice President of Global Research Technologies at Novo Nordisk
Check Out Our Reviews
Higher insulin resistance with lower vitamin D: HOMA-IR values increased progressively as vitamin D status declined, indicating greater insulin resistance in those with lower serum 25(OH)D levels
Common, temporary side effects may include: Mild nausea Temporary digestive changes Decreased appetite Occasional fatigue during dose adjustments Most symptoms are dose-dependent and improve as the body adapts